Jing Zhang

Professor at Beihang University, recipient of the National Young Talent Program (Overseas Excellent Young Scholar), academic leader in Bioinformatics and Intelligent Computing, Youth Committee Member of the World Association for Chinese Biomedical Engineers, Editorial Board Member of Neuropsychiatric Research, and Responsible Editor of Medicine in Novel Technology and Devices. He/She has published over 30 SCI-indexed papers with cumulative citations exceeding 1,200, and has successively undertaken projects under the National Natural Science Foundation of China, national-level talent programs, and ministerial-level talent programs. These achievements have begun to be applied in clinical diagnosis and treatment (for example, the TMZ chemotherapy efficacy-predicting marker miR-181d has been included in the Clinical Diagnosis and Treatment Guidelines for Brain Glioma (2022 Edition) issued by the National Health Commission).